EP3231444
NÝ MEÐFERÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.5.2015EP published:
18.12.2019EP application number:
17174446.9
EP translation filed:
20.2.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
10.5.2035Expiry date:
10.5.2026Next due date:
31.5.2026
Title:
NEW TREATMENT
Timeline
Today
11.5.2015EP application
18.12.2019EP Publication
20.2.2020Translation submitted
15.4.2020Registration published
10.5.2026Expires
Owner
Name:
Verona Pharma PLCAddress:
One Central Square, Cardiff CF10 1FS, GB
Inventor
Name:
ABBOTT-BANNER, KatharineAddress:
London, Greater London SE1 2RE, GB
Name:
HANRAHAN, JohnAddress:
Montreal, Québec H3G 1Y6, CA
Name:
THOMAS, DavidAddress:
Montreal, Québec H3G 1Y6, CA
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201408384Date:
12.5.2014Country:
GB
Number:
201417719Date:
7.10.2014Country:
GB
Classification
Categories:
A61K 45/06, A61K 31/404, A61K 31/47, A61K 31/519, A61P 11/06
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 7.4.2020
Expires: 10.5.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.4.2021
Expires: 10.5.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.4.2022
Expires: 10.5.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.4.2023
Expires: 10.5.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.4.2024
Expires: 10.5.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.4.2025
Expires: 10.5.2026
Payer: Árnason Faktor ehf.